FRENCH AND AREA SCIENCES & BUSINESS LEADERS WEIGH IN ON NEW ENGLAND’S MOMENTUM, OPPORTUNITIES & CHALLENGES IN THE YEAR AHEAD.
2014 has been a blockbuster year for the Life Sciences industry. We witnessed an IPO record for biotechs in the region in the decade with 17 companies combined to raise about $1.1 billion; several M&A deals between big pharma and biotech companies and more than 40 new molecules and licenses approved by the FDA.
Issues to be likely face in the near future include the debate about price tag for medicines to treat rare and chronic diseases, big data management among others.
Join us to meet local companies, researchers, sciences & business leaders from both sides of the Atlantic as they analyze fast-changing development in Life Sciences both in New England and Europe. This program will address topics of interest for small and large companies, investors such as medical devices, regulation, nanotechnologies and finances.
Welcome Address by Marc Esteva, CFO, Genzyme.
6:05-6:30: Overview of 2014 Headlines in Life Sciences & 2015 Perspectives
Don Seiffert, BioFlash Editor, Boston Business Journal
Shahin Gharakhanian, MD, Program Committee Leader, FABS
6:30-7:00: Panel #1: Value for Money
Panelists: Bernard Davitian, VP & Managing Director, Sanofi-Genzyme BioVentures/ Pravin Chaturvedi, Ph.D., Moderator, MassBio Meeting on Value Creation in the Biotech Industry: Chairman & CEO, IndUS Pharmaceuticals/ Dennis Ford, CEO Life Science Nation/ Richard Gill, Ph.D., Launchpad Board DIrector and Investing Member.
7:00 - 7:30 Keynote address: Medical Services
Professor Steven McCarthy, Massachusetts Medical Device Development (M2D2) Center, University of Massachusetts, Lowell MA
7:20- 7:40: Keynote address: Big Data
Iya Khalil, PhD, Executive VP & Co-Founder, GNS Healthcare, Cambridge MA
7:40-8:10: Panel #2: Innovation & New Trends
Panelists: Leslie S. Sloan, Ph.D., President & VP R&D Project Management & Analytics, IPSEN Bioscience /Patrick Tricoli, MD, MBA, CEO & VP Corporate Development, Nanobiotix Corp. / Emmanuelle M. Voisin, Ph.D, CEO & Founder, Voisin Consulting Life Sciences (VCLS)
Moderator: Jean-Jacques Yarmoff, Ph.D.
Attaché for Science and Technology, Embassy of France in the US
$35 FACCNE Members and Partners
5:30 - 6:00pm Registration & Networking
6:00 - 8:10pm Program
8:10 - 9:00pm Networking Cocktail
|FACCNE staff and volunteers, FABS Members, Genzyme/Sanofi Employee||$ 0.00|
|FACCNE Members||$ 35.00|
|Full-Time Students and YP Members||$ 20.00|